OXYCODONE 5 Drug Patent Profile
When do Oxycodone 5 patents expire, and when can generic versions of Oxycodone 5 launch?
Oxycodone 5 is a drug marketed by Bristol Myers Squibb and is included in one NDA.
The generic ingredient in OXYCODONE 5 is acetaminophen; oxycodone hydrochloride. Twenty-nine suppliers are listed for this compound. Additional details are available on the acetaminophen; oxycodone hydrochloride profile page.
US Patents and Regulatory Information for OXYCODONE 5
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bristol Myers Squibb | OXYCODONE 5/APAP 500 | acetaminophen; oxycodone hydrochloride | TABLET;ORAL | 085911-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
